TrialJAMA network open2020

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.

Benoist Chibaudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.